Nicholas J. Van Wagoner, Ph.D.
|2000||University of Alabama, Birmingham, Birmingham, AL, United States|
Google:"Nicholas Van Wagoner"
Mean distance: 21.25 (cluster 6)
ParentsSign in to add mentor
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Choi C, Gillespie GY, Van Wagoner NJ, et al. (2002) Fas engagement increases expression of interleukin-6 in human glioma cells. Journal of Neuro-Oncology. 56: 13-9|
|Lee SJ, Drabik K, Van Wagoner NJ, et al. (2000) ICAM-1-induced expression of proinflammatory cytokines in astrocytes: involvement of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways. Journal of Immunology (Baltimore, Md. : 1950). 165: 4658-66|
|Van Wagoner NJ, Choi C, Repovic P, et al. (2000) Oncostatin M regulation of interleukin-6 expression in astrocytes: biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38. Journal of Neurochemistry. 75: 563-75|
|Van Wagoner NJ, Benveniste EN. (1999) Interleukin-6 expression and regulation in astrocytes. Journal of Neuroimmunology. 100: 124-39|
|Van Wagoner NJ, Oh JW, Repovic P, et al. (1999) Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 5236-44|
|Oh JW, Van Wagoner NJ, Rose-John S, et al. (1998) Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression. Journal of Immunology (Baltimore, Md. : 1950). 161: 4992-9|
|Van Wagoner NJ, O'Keefe GM, Benveniste EN. (1998) Kinase inhibitors abrogate IFN-gamma-induced class II transactivator and class II MHC gene expression in astroglioma cell lines. Journal of Neuroimmunology. 85: 174-85|